Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.40
+0.13 (2.47%)
At close: Oct 31, 2024, 4:00 PM
5.47
+0.07 (1.30%)
After-hours: Oct 31, 2024, 6:33 PM EDT

Amylyx Pharmaceuticals Market Cap

Amylyx Pharmaceuticals has a market cap or net worth of $367.65 million as of October 31, 2024. Its market cap has decreased by -69.50% in one year.

Market Cap
367.65M
Enterprise Value
52.12M
1-Year Change
-69.50%
Ranking
Category
Stock Price
$5.40

Market Cap Chart

Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $367.65M, a decrease of -65.61%. That is a compound annual growth rate of -31.57%.

History

DateMarket Cap% Change
Oct 30, 2024358.80M-63.90%
Dec 29, 2023993.90M-59.40%
Dec 30, 20222.45B128.98%
Jan 7, 20221.07B-
View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
ZimVie 385.45M
Voyager Therapeutics 382.82M
Nyxoah 368.30M
Anika Therapeutics 364.89M
ClearPoint Neuro 362.88M
Alpha Teknova 358.73M
Enhabit 358.52M
DocGo 355.04M
Market Cap Rankings